$49.72
6.2314.33%
At close: -
$49.93
0.210.42%
After Hours: Feb 14, 7:59 PM EDT
Comments
Loading...
Latest news for CRISPR Therapeutics (NASDAQ:CRSP) Stock
CRISPR Therapeutics Stock (NASDAQ: CRSP)
Categories: All
Sunday, February 16, 2025
Friday, February 14, 2025
- This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- This Informatica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
- CRISPR Therapeutics shares are trading higher...
- Morgan Stanley Maintains Underweight on CRISP...
- This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
- Evercore ISI Group Upgrades CRISPR Therapeuti...
Thursday, February 13, 2025
Wednesday, February 12, 2025
- Truist Securities Maintains Buy on CRISPR The...
- RBC Capital Maintains Sector Perform on CRISP...
- Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
- CRISPR Therapeutics shares are trading higher...
- Needham Reiterates Buy on CRISPR Therapeutics...
- Barclays Maintains Equal-Weight on CRISPR The...